Skip to main content

Anand and Anand recognised amongst FT25 in FT Asia-Pacific Innovative Lawyers 2016

Anand and Anand has been recognised for a second year running in Financial Times Asia-Pacific Innovative Lawyers 2016. The firm has been ranked in FT25, a list of the 25 most innovative law firms in the Asia-Pacific.

Anand and Anand is also the the only Asia headquartered firm to feature in Business of Law – Technology; and the only Asia headquartered firm for Analytics.

Our Digital Learning initiative helping staff develop skills towards digital communication and analytics was “Highly Commended”. Our data collection and analytics efforts have been “Commended” for their embrace across all practices.

In 2015, FT had picked Pravin Anand as the “unanimous” winner of Asia-Pacific Innovative Lawyers for the “key role he has played in helping to develop intellectual property law in India”.

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Nov 07, 2026

Pharmaceutical innovation and access to medicines are closely connected aspects of public health. While patent protection can encourage investment in research

Can Public Health Override a Pharmaceutical Patent? The BPaL Patent Dispute in India
News & Updates, Thought Leadership
•
Nov 04, 2026

Imagine discovering an Instagram account using your company’s name, a website offering products under a deceptively similar identity, or an AI-generated

Can AI Steal Your Brand Identity? Trademark Squatting and AI Misuse in India
News & Updates, Thought Leadership
•
Nov 02, 2026

First published by AsiaIP. Author: Lakshmidevi Somanath Copyright law has traditionally addressed the asymmetry between the costs of creating a work and

What is Copyright Worth When Machines Do the Creating? Lessons from Streaming and Gaming
News & Updates, Thought Leadership
•
Oct 31, 2026

A startup has developed a new technology, filed a patent application and begun building its product. The filing is an important milestone. But what happens

Your Startup Has Filed a Patent. Now What? The Commercial Value of IP